Physicians Off The Beaten Path: Recent Episodes
Physicians Off The Beaten Path
This is a podcast where we’ve set out to bust the myth that physicians cannot venture outside the traditional clinical or research career path. We plan to do this by chatting with physicians who have done amazing work in a diverse range of careers, whether in consulting, investing, as an entrepreneur, a writer, and many more. We really hope to explore it all! If you've found our work helpful, buy us a coffee! https://bmc.link/potbpp
How do you take that first step and balance clinical duties with non-clinical interests? What specific advances in biotech could have the potential to revolutionize clinical treatment in the near future? What factors are you optimizing for in your career plan? Join this episode as Dr. Sam Kessel answers these questions and more and shares his story!
Sam completed his intern year in internal medicine. He was an associate for multiple angel networks, performing part-time due diligence on medical startups during medical training. He then went on to become a Consultant at LEK Consulting. He is now an associate at Locust Walk, where he works with various biotech companies using cutting-edge technologies to help them find partners and funding. He hosts the Nucleate Signal podcast and interviews folks who are the next generation of leaders in biotech.
He got his Bachelor's from Tufts University, MD from the University of Virginia School of Medicine, and MBA from the University of Virginia Darden School of Business.
We volunteer our time and money to make this content freely available – if you enjoy our content and find it helpful, you can support us by buying us a coffee here!
How can we, as MDs, ensure better representation of low-resource countries in the digital healthcare movement? What are the means to enhancing healthcare access through AI-led digital acceleration? How can you generate building blocks to guide your entrepreneurial journey? Dr. Alice Jacobs, CEO of Convergence Group, answers all these questions and more.
Alice is a physician and entrepreneur. She leads the Convergence Group, which works on improving access to and delivery of healthcare through AI-led digital acceleration. She founded her first company, IntelligentMDx, after losing a patient from a staph infection. She has worked with leading venture funds, including Third Rock Ventures/MIT/Bob Langer, GE Ventures, and GreyBird Ventures. She spent two years as an Entrepreneur-in-Residence at Caltech, guiding efforts to build the next generation of deep technology solutions.
She was recognized by Scientific American as one of the top 50 innovators and by the World Economic Forum as a Young Global Leader, a 40 under 40 award by the Boston Business Journal, and for Healthcare Innovation in Clinical Diagnostics by Frost & Sullivan.
She holds a BA in Art History, a BS in Biological Sciences from Stanford with Honors in Developmental Neurobiology, and an MD from Harvard Medical School.
What did you optimize for when choosing the first position outside the clinical path? What are the challenges that M.D.s could encounter when leaving clinical medicine? What is the role of immigrant mentality in building risk tolerance? Dr. Shehnaaz answers!
Dr. Shehnaaz Suliman is a visionary physician, drug developer, and dealmaker with over 25 years of experience reshaping the biotech landscape. She is C.E.O. and board member at ReCode Therapeutics, an integrated genetic medicines company located in California that works on developing disease-modifying therapeutics using its powerful L.N.P. delivery technology to target organs and tissues beyond the liver. She was formerly president and C.O.O. at Alector, a clinical-stage biopharmaceutical company. Her professional experience began in 2001. Since then, Shehnaaz has changed six roles and seven companies, such as Theravance Biopharma, Genentech, Roche Partnering, Gilead Sciences, Lehman Brothers and Petkevich & Partners, Ultragenyx Pharmaceutical, and 10X Genomics.
Dr. Suliman received her M.D. from the University of Cape Town Medical School, South Africa. She also holds an M.B.A., with distinction, and an M.Phil. in development studies from Oxford University, where she was a Rhodes Scholar. She was named one of the 2017 Fiercest Women in Life Sciences and one of the National Diversity Council’s Power 50 in 2021 (Most Influential Women in Business). Recently, Shehnaaz was featured on the 2023 Forbes 50 over 50 and was recognized as the 2023 Women of Influence by the Silicon Valley Business Journal.
Dive into a seasoned venture capitalist's mind as they look at today's landscape! Dr. Farzad Soleimani is sharing valuable insights on:
- Hands-on exposure to fields such as engineering and business
- The skills and capabilities needed for success outside clinical medicine
- The role of dual degree programs like MD/MBA
- What do the best founding teams have in common
Farzad is the Healthcare Partner at 1984 Ventures, having seeded companies such as Trusted Health, Deep Scribe, Health Note, and Signos. He is the founder of eTherapi, a pioneering telemedicine company, and the founding co-director of the Texas Medical Center Biodesign Innovation Program. He started his investing career at MohrDavidow Ventures and continued to work at a number of innovation startups, such as Pocket Naloxone, Hansen Medical, and IGAN Biosciences.
Farzad completed his residency training at Baylor and earned his MBA, MD, MS, and BS from Stanford University. He is on faculty at Baylor Medical School, Rice Business School, and Rice Bioengineering Department.
We volunteer our time and money to make this content freely available – if you enjoy our content and find it helpful, you can support us by buying us a coffee here!
Unlocking Hyper-Personalized Learning in Medicine! Join us for an insightful chat with Dr. Sievert Weiss, co-founder of AMBOSS. Discover how digital tools create tailored learning experiences for aspiring medical professionals.
Sievert is a physician by training and a self-taught med-ed-tech co-founder who is notoriously curious to explore ways to improve healthcare and has an interest in public and global health issues. In 2012, right after graduation, he co-founded AMBOSS, a German medical technology company. Their mission is to improve global health by empowering physicians worldwide to apply the best care possible. Today, more than 2 million healthcare professionals in over 170 countries rely on AMBOSS. Sievert studied medicine in Germany, Portugal, and Brazil. He studied at the University of Göttingen.
How should physicians navigate the distinction between physicians as citizens vs. physicians as professionals as it relates to policy advocacy? How can we rally different social norms and regulatory frameworks toward the intended change point? How would clinical practice ignite and foster advocacy work?
In this episode, Dr. Ana Cristina González Vélez answers all these questions and delves into her journey of advocating for women’s reproductive rights!
Ana Cristina González Vélez is a Colombian reproductive rights activist and medical doctor. She is a known international researcher, advocate, and expert in the field of sexual and reproductive health as well as gender equality. She is the founder and active member of La Mesa por la Vida y la Salud de las Mujeres, Colombia, the team coordinator of the Feminist group Mercosur, and the founder and coordinator of the Medical Group for the Right to Decide in Colombia.
Ana holds an MD from Pontifical Bolivarian University in Colombia, a master’s degree in social health research from the Center for Study on State and Society in Buenos Aires, Argentina, and a Ph.D. in Bioethics from Fiocruz Foundation in Brazil. She is currently a Fellow at the Harvard LEAD Fellowship for Promoting Women in Global Health.
How can you get involved in shaping healthcare policy rather than just be shaped by it? How can policy work make you a better clinician and a better advocate for your patients? What are hospital "never events"?
Join our 47th episode featuring a panel discussion with Dr. Farzad Mostashari and Adam Beckman.
Dr. Farzad Mostashari has spent his career at the forefront of healthcare policy and health information technology. He is the Co-Founder and CEO of Aledade, a primary care enablement company that partners with independent private care practitioners to transition to value-based care and, as a result, maintain their independence. Dr. Mostashari received his MD from Yale University School of Medicine and his Masters in Population Health from Harvard TH Chan School of Public Health. He did an internal medicine residency at Massachusetts General Hospital.
Adam Beckman was a joint MD-MBA student at Harvard Medical School and Harvard Business School. Adam took a leave of absence from his MD/MBA program at Harvard Medical School in 2021 to serve as a special advisor to US Surgeon General Vivek Murthy. In 2022, he was featured on Forbes' 30 healthcare leaders under 30. Adam holds a Bachelor Of Arts/Science from Yale University. He finished his MD-MBA programs at Harvard Medical School and Harvard Business School in May 2023.
What are outcome-based payment agreements or VBAs, and how can MDs develop innovative financing models? What do the next few years hold for VBAs in therapeutics and diagnostics? How can we mentor young docs looking to venture off the beaten path? Join us as Dr. Micahel Sherman answers these questions and discusses mentorship, supporting VBAs, the Inflation Reduction Act, and many other topics.
Michael is currently a Venture Partner at RA Capital. Michael is formerly an executive vice president and the chief medical officer at Point32Health, formed by the merger of Harvard Pilgrim Health Care and Tufts Health Plan. Michael is known as a pioneer in developing outcomes-based payment agreements and bringing novel interventions to patients. He signed the first outcomes-based contract for a gene therapy in the US.
Michael holds an M.D. from Yale University, an MBA from Harvard Business School, and master’s and bachelor’s degrees from the University of Pennsylvania.
How important is it for physicians to be translators who can merge technology with healthcare? What are the characteristics that make the Singaporean healthcare system unique on a global level? How can we foster a better teamwork mentality across physicians? In this episode, Dr. Zubin Daruwalla explores these topics and more!
Zubin Daruwalla is the PwC Singapore Health Industries Leader and sits on PwC’s Global Health Leadership Team. He is also a Co-Founder of HiruX. He has delivered over 100 talks and presentations, including multiple keynotes in more than 12 countries and across 5 continents.
After graduating with honors from the Royal College of Surgeons in Ireland in 2005, Zubin commenced and continued his practice of medicine in Dublin. He subsequently pursued a career in orthopedic surgery. He was awarded the Membership of the Royal College of Surgeons in Ireland (MRCSI) in 2008, followed by a Master's in Orthopedic Surgery (MCh, Orth) in 2010.
Named one of the most influential and emerging voices in the global health industry in 2021 and the Top 50 Most Influential Voices of Healthcare in 2022, he hopes to help bridge the gap between the technical and clinical sides of digital health.
Join us as Lincoln Nadauld, CEO of Culmination Bio, delves into the crucial role of genomics-powered precision medicine in Oncology research. Discover the main challenges hindering the adoption of precision medicine in clinical oncology. Gain insights on effectively managing your time between clinical medicine and the industry. Don't miss Lincoln's inspiring journey!
Lincoln Nadauld is the CEO of Culmination Bio, a biotech company leveraging unique data sets from diverse biosamples containing vast biological data enriched with clinical data.
He was VP and Chief of Precision Health and Academics at Intermountain Healthcare, where he led precision health across 24 hospitals and 200 clinics, overseeing Graduate Medical Education. He is the co-founder of Clarified Precision Medicine as well as Guidance Genome.
Lincoln graduated from Bountiful High School. He played rugby while getting his undergraduate degree at BYU, his Doctor of Medicine, and his Doctor of Philosophy from the University of Utah. Then he did his clinical training in oncology at Stanford University.
What factors must we overcome for healthcare Machine Learning to reach its full potential? How can LMICs globally be included in the healthcare informatics and data ecosystem?
Join this episode as Dr. Leo Anthony Celi answers these questions and talks about the future of AI in health!
Leo is the Clinical Research Director and Principal Research Scientist at the Massachusetts Institute of Technology Laboratory of Computational Physiology and a Staff Physician at the Division of Pulmonary, Critical Care, and Sleep Medicine at Beth Israel Deaconess Medical Center. He holds an MPH in Clinical Effectiveness from Harvard University School of Public Health, an MSc in Biomedical Informatics from MIT, and an MD in Medicine from the University of the Philippines.
How does one identify the market opportunity and the go-to-market strategy? And how can one drive market adoption while being a practicing physician? What is the current state of medical education? And how can it improve to unleash the creative potential of doctors? David Grew addresses these questions and other topics on our 42nd episode.
David is the founder of PRIMR, an application that allows physicians to provide patients with digitally recorded, personalized explanations regarding their medical conditions and treatments.
David is a Connecticut-based radiation oncologist practicing at Trinity Health of New England. He holds an MD from Tulane University School of Medicine and an MPH from Tulane University School of Public Health and Tropical Medicine.
What are some of the inflection points that are needed to unlock the commercial side of the market of digital therapeutics? How can MDs demonstrate that they’ll add value in areas of interest to a prospective employer? In our 41st episode with Dr. Andrey Ostrovsky, we answer all these questions and more!
Andrey is Managing Partner at Social Innovation Ventures. He was the CMO of the US Medicaid Program, where he helped Medicaid develop its opioid strategy, plant the foundation for becoming a learning organization, and move toward data-driven policymaking. He also advocated for accurate, accountable, and ethical dissemination of information from the government to the public. Andrey holds an MD from Boston University School of Medicine and undergraduate degrees in Chemistry and Psychology. He is a member of Phi Beta Kappa. Andrey completed his pediatrics residency training in the Boston Combined Residency Program at Boston Medical Center and Boston Children’s Hospital, where he was a clinical instructor at Harvard Medical School.
How to optimize telehealth and digital medicine to create a helpful layer of privacy? How to protect your competitive edge in the market? How to address the needs of a sensitive market such as women's sexual health? In our 40th episode, we discuss those topics and more with Dr. Lyndsey Harper.
Lyndsey is an Obstetrician and Gynecologist, an Associate Professor of Ob/Gyn for Texas A&M College of Medicine, a Fellow of The American Congress of Obstetricians and Gynecologists, and a Fellow of the International Society for the Study of Women's Sexual Health. Lyndsey is the Founder and CEO of Rosy Wellness, a sexual Wellness app that started in 2019 which connects women who have sexual health concerns with hope, community, and research-backed solutions. She has been named Forbes Top 53 Women Disrupting Healthcare, People Newspapers’ 20 Under 40, a Top Innovator in North Texas for 2020, and a DBJ Top Women in Technology honoree.
Dr. Harper earned a BS in Microbiology and an MD from The University of Arkansas. Dr. Harper completed an OB-GYN residency at Baylor University Medical Center in Dallas, Texas. She is now an Ob-Gyn Hospitalist at Baylor Scott & White Health in Dallas.
Why is the cross-pollination of ideas so important in healthcare? How and when to jump into entrepreneurship? What is perceptual AI? How to use video games for good? How to promote wellness through esports? In this episode, we answer all these questions and more with Dr. Khizer Khaderi, MD, MPH.
Khizer is a Neuro-Ophthalmic surgeon. He is a Clinical Associate Professor at the Byers Eye Institute at Stanford University, the Director/Founder of the Stanford Human Perception Laboratory (HPL) and the Stanford Vision Performance Center (VPC), and faculty at the Stanford Institute for Human-Centered AI. Khizer is an advisor to Magic Leap, NBA, Aerie Pharma, the Global Esports Federation, CompHealth Global, and the World Health Organization. He is the Founder of Vizzario Inc, a perceptual AI company. He graduated from the University of Utah in 2002 and did a residency in ophthalmology at the University of Arizona.
How important is it to have a teamwork mentality in medicine? What values does humanitarian work add to someone’s perspective, and how can it affect their entrepreneurial career? How can we, as MDs, take action steps towards better care at the end of the day and make a positive influence in the most straightforward ways? This episode answers all these questions and more as we explore Dr. Naji Gehchan’s journey of growing up and working in settings of war and tension and how he overcame these challenges.
Naji is the co-founder of Sohati, a healthcare startup serving the Middle East, and the host of the podcast “SpreadLove In Organizations,” where he interviews leaders from across the globe on their personal stories and how they spread love in their organizations for people to feel safe to thrive and deliver positive impact for the company’s stakeholders. He holds an executive MBA from MIT Sloan.
What additional barriers often affect women and minorities and make the medical journey even harder? How can we employ the stories of women of color to motivate aspiring female physicians and physicians of color? In our next episode, we answer these questions and explore the story of Jasmine Brown, who dedicated her academic research at the University of Oxford to explore the lives of pioneering African American female physicians. We discuss her recently published book “TWICE AS HARD”
Jasmine is an MD Candidate at the University of Pennsylvania. She completed a Bachelor of Arts in Neuroscience at Washington University in St. Louis, then an MPhil in the History of Science, Medicine, and Technology at the University of Oxford supported by the Rhodes Trust. She has been involved in advocacy work for many years helping minority students get involved in research. Jasmine just released her first book, “TWICE AS HARD”. The book covers the history of Black women physicians in the US from the civil war to the 21st century.
How do we channel efforts toward curing preventable blindness? What is the influence of social media with a wide audience in bringing light to certain issues and making a profound impact on the ground? In this episode, we talk with Dr. Jeffrey Levenson about curing needless blindness, his latest collaboration with MrBeast to restore eyesight for 1000 patients, the role of private philanthropy and government in healthcare, the different viewpoints regarding the collaboration, and the role of social media in highlighting specific issues. Jeff is a board-certified ophthalmologist and the Chief Medical Officer of SEE International which is a non-profit humanitarian organization that seeks to provide eyecare services to anyone in need of them, regardless of their background or ability to pay. He is also the medical director of Levenson Eye Associates in Jacksonville, Florida. He is active with several charitable medical organizations including Volunteers in Medicine, Vision is Priceless, and We Care Jacksonville. He recently joined efforts with the famous YouTuber MrBeast to restore eyesight for 1000 patients, a project that yielded varying reactions and raised great interest and 100 million views!
What can we contribute to the different areas of healthcare, and how can we as MDs demonstrate added value in areas beyond clinical care? How can you contribute to important decisions that drive the future of the sector? And how essential is AI and machine learning for the process, and the future of medicine in general? in this episode, we answer all these questions and more through an enlightening talk with our guest, Dr. Jonathan Ng, CEO at Iteartive Health.
Jonathan is the CEO of Iterative Health, a pioneer in the application of artificial intelligence-based precision medicine to gastroenterology with the aim of establishing a new standard of care for the detection, and ultimately, treatment of gastrointestinal (GI) diseases.
Jonathan is Chairman at Children of Cambodia (Singapore), a nonprofit organization that aims to improve the lives of children and families in Cambodia by providing better healthcare facilities. He specifically worked for Advancing comprehensive medical education solutions in Cambodia and South East Asia.
He is the Co-Founder of Optimimed Pte Ltd, a research and experimental development on medical technologies business-based company which is located in Singapore. Previously, he was a medical officer at the Hospital Services Division in the Ministry of Health, Singapore.
Jonathan holds an MD from the National University of Singapore, an MBA from Massachusetts Institute of Technology, and an MPA in healthcare policy from Harvard Kennedy School.
How to venture early off the beaten path? How to gain multiple skills and still focus on investments in healthcare and life sciences from early to growth stages? How to venture in the domain of healthcare technologies and accumulate experience in heakthcare IT startups?
And many more questions are to be answered in today's episode with Morgan Cheatham.
Cheatham. Morgan is a Vice President at Bessemer Venture Partners, a global venture capital firm with over $19 billion in assets under management, where he focuses on investments in healthcare.
Morgan was accepted to medical school at age 17 and was working as a data scientist at a healthcare startup by age 19. Morgan is pursuing his medical degree at The Warren Alpert Medical School of Brown University and graduated magna cum laude from Brown University with a B.S. in neuroeconomics
Recently, Morgan was featured on Forbes List 30 Under 30 for Venture Capital (2023)
What role do innovations in telehealth play in space medicine? What are the main medical issues astronauts face in space and what mitigation and treatment strategies do they use? In this episode, we answer all these questions and more, with our guest, Daniel Grant.
Daniel is Head of Medical Education at Medichecks, the UK's leading online blood-testing company. He is also creator of The Stealth Doctor output. Across multiple platforms, he aims to educate and enlighten everyone about how we can all get healthier through all the things you didn’t even know were related to your health.
He is also the CEO of UK Wallball, the governing body for the sport of Wallball in the United Kingdom. He holds an MD from UCL.
What are the key problems we have today in surgical training? How should you think about the risk/reward of going down the entrepreneurship path? In this episode, we answer all these questions and more with our guest, Justin Barad, MD.
He is the co-founder and CEO of Osso VR, an award winning surgical training platform helping to increase patient saftey and the adoption of cutting edge medical technology.
He is a board-eligible orthopedic surgeon with a Bioengineering degree from UC Berkeley, and an MD from UCLA, where he graduated first in his class.
How can AI innovation help in transforming the future of Endocrinology? What are the main problems we have with the US healthcare system, and what roles can MDs have in solving these problems? In this episode, we answer all these questions and more, with our guest, Mansur Shomali, M.D.
He is Chief Medical Officer at Welldoc, a healthcare technology company that develops solutions to transform the management of chronic disease.
Mansur received his undergraduate degree in biomedical engineering at the Johns Hopkins University and his medical degree from McGill University in Montreal, Canada.
What makes Nomad Health, the first digital marketplace for healthcare jobs, a unique and innovative tool? Why is it important to look at the "MD" as a platform degree? In this episode, we answer all these questions and more, with our guest, Alexander Nazem, MD.
Alexander is Co-Founder and CEO of Nomad Health, the first digital marketplace for healthcare jobs, which directly connects physicians, nurses, and medical facilities for healthcare jobs, without the involvement of third party employment agencies.
He has an MD from Yale University, an MBA from HBS, and a BS in Molecular Biophysics & Biochemistry from Yale.
How can medicine and art influence each other? What makes practicing medicine an art itself? In this special episode, we answer all these questions and more with our guest, Mike Natter, MD.
Mike is a freelance artist, contributor and writer at Philadelphia Inquirer. He was featured in “Art from the Frontlines: Visual Expressions from Medical Professionals During the COVID-19 Pandemic”, an exhibit that highlighted artwork created by healthcare professionals during the COVID-19 pandemic as well as in-depth interviews with the artists.
Mike has an MD from Thomas Jefferson University, a Medical Sciences Certificate from Columbia University in NYC, and a BA in Neuropsychology from Skidmore College.
What are the biggest barriers to digital therapeutics, and how will the field evolve down the line? How can we make MDs excited about entrepreneurship and innovation, like DTx for example, where their experience and clinical knowledge is actually needed?
In this episode, we answer all these questions and more, with our guest, Dr. Shaheen Lakhan.
Shaheen is the CMO of Click Therapeutics, A prescription digital therapeutics company that develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs.
Shaheen is a physician-scientist with over 15 years of experience in healthcare, academia, and industry focusing on neuroscience research and development.
Shaheen is board-certified in both neurology and pain medicine, with clinical training from Cleveland Clinic and Massachusetts General Hospital.
What kind of opportunities medical students have if they don’t want a traditional medical career? Why is it important to think about medical training as a platform, rather than a predetermined path? In this episode, we answer all of these questions and more, with our guest, Olivia Cavlan MD.
Olivia is Chief Corporate Development and Strategy Officer at Alchemab Therapeutics Ltd, a biotech company developing novel products for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies.
Olivia holds an MD in Medicine and a BSc in Pharmacology from Bristol University where she graduated with the top First Class Honors.
What are the most important things you need to have in order to succeed in a nontraditional path? How can you keep evolving in an ever-changing world? In this episode, we answer all these questions and more with our guest, Dr. Alex Ding.
Alex is Executive in Residence & Medical Director at the Office of Health Affairs and Advocacy at Humana, a for-profit American health insurance company based in Louisville, Kentucky, and the third largest health insurance provider in the nation. He is Clinical Assistant Professor of Radiology at the University of Louisville.
Alex holds an M.S. in Health & Medical Sciences from School of Public Health at University of California, Berkeley, and a BA in Economics from the same University. He holds an MD from UCSF, and an MBA from The Wharton School, University of Pennsylvania.
What is the role of profit in healthcare and how can that incentive be used to create value for society and for patients? What can the medical curriculum learn from the business curriculum, and vice versa?
In this episode, we answer all these questions and more with our guest, Elizabeth Kwo, MD.
Elizabeth is the Chief Medical Officer at Everly Health, a healthcare company that aims to provide modern diagnostics-driven care.
She is an experienced healthcare executive specialized in building and scaling digital healthcare products to provide high quality care, leveraging predictive and prescriptive analytics to improve outcomes.
She is a physician at Cambridge Health Alliance, an affiliated teaching hospital of Harvard Medical School, and a lecturer for Harvard Medical School students and Preventive Care and Occupational Medicine residents.
Dr. Kwo has an MD from Harvard Medical School, MBA from Harvard Business School, MPH from Harvard TH Chan School of Public Health, and a BA from Stanford University. She completed her residency at Harvard and is Board Certified in Preventive Care and Occupational Medicine.
How does turning the way we receive care inside out actually improve care and decrease costs? What are some of the strategies we can actually use to make things better for everyone? In this episode, we answer all these questions and more with our guest, Vivian Lee, MD.
Vivian is President of Health Platforms at Verily Life Sciences, an Alphabet company whose mission is to apply digital solutions that enable people to enjoy healthier lives. She also serves as a Senior Lecturer at Harvard Medical School and Massachusetts General Hospital, and a Senior Fellow at the Institute for Healthcare Improvement.
She is the author of the acclaimed book, “The Long Fix: Solving America’s HealthCare Crisis with Strategies that Work for Everyone”.
Vivian is a magna cum laude graduate of Harvard-Radcliffe Colleges, received a doctorate in medical engineering from Oxford University as a Rhodes Scholar, earned her M.D. with honors from Harvard Medical School, and was valedictorian of her Executive MBA program at NYU’s Stern School of Business.
Is there a specific path to entrepreneurship MDs need to follow? What does the demand and supply dynamics in the nursing market look like? How can we address labor shortages in healthcare more efficiently? In this episode, we answer all these questions and more, with our guest, Iman Abuzeid, MD.
Iman is the co-founder and CEO of Incredible Health, Inc. A digital platform designed to streamline the hiring and recruitment process for nurses.
Iman holds an MD from University College London Medical School, and an MBA from Wharton School, University of Pennsylvania.
Visit Incredible Health's website to learn more about the platform: https://www.incrediblehealth.com/
What needs to happen to encourage more entrepreneurship among MDs? What can MDs learn from chaos theory? How can you use your immigrant mentality as a drive to do more, not to take the well-known and secure path? In this episode, we answer all these questions and more with our guest, Mohammad Al-Ubaydli, M.D.
Mohammad is founder and CEO of Patients Know Best, a British social enterprise, with an aim of putting patients in control of their own medical records.
He trained as a physician at the University of Cambridge; worked as a staff scientist at the National Institutes of Health; and was a management consultant to US hospitals at The Advisory Board Company.
Mohammad holds an MD from Cambridge University.
How did Osmosis, the popular health education platform, come about? Why do we need more MDs in spaces like health policy? In this episode, we answer all these questions and more with our guest, Shiv Gaglani.
Shiv is the co-founder and chief executive officer of Osmosis, which makes a popular web- and mobile-learning platform used by more than 3 million medical and allied health professions students and 30+ medical schools.
After graduating magna cum laude from Harvard College in 2010 with degrees in engineering and health policy, Shiv began his MD degree at the Johns Hopkins School of Medicine and earned his MBA from Harvard Business School in 2016.
Is it important for MDs to consider taking a more prominent role in the process of developing and getting drugs to market, either on the operating side or the investing side? How can we change and fix financial incentives in drug development? In this episode, we answer all these questions and more with our guest, David Kaufman, M.D.
David is a Partner at Third Rock Ventures, a leading healthcare venture firm that specializes in company creation rather than the traditional venture investing model.
David has an MD from Cornell University, and a PHD in immunology and molecular virology from Rockefeller University.
Why is there a mismatch between VC companies and some vulnerable patient populations? Do we need a radical transformation from the ground up of the medical curriculum? Are there any similarities between clinical and athletic training and investing? In this episode, we answer all of these questions and more with our guest, Justin Norden, MD.
Justin is a Partner at GSR Ventures, where he focuses on early-stage investments in digital health, AI/ML in healthcare, and enterprise technology.
Justin received his MD from Stanford University School of Medicine, MBA from the Stanford Graduate School of Business, M.Phil in Computational Biology from the University of Cambridge, and BA in Computer Science from Carleton College.
How can physicians leverage their previous experiences and strengths to transition to becoming good entrepreneurs? What does the future look like for innovation in Ophthalmology? In this episode, we answer all these questions and more with our guest, Sophia Pathai, M.D.
Sophia is a Venture Partner at Peppermint Venture Partners, a VC firm based in Berlin investing in early-stage healthcare companies across Europe. She invests in early-stage MedTech and BioTech with an ophthalmology focus. She is also an independent consultant, advising investors and founders on BioTech and MedTech portfolio companies and design of TPP to gain financing and eventual commercialization.
Sophia holds a medical degree from University College London Medical School; a Masters in Epidemiology from the London School of Hygiene & Tropical Medicine (LSHTM) and a Ph.D in ophthalmology and immunology also awarded from LSHTM.
Is it necessary to focus your efforts on a single area or is it wiser to follow your passion wherever it might lead you? Why is it important for MDs to explore areas beyond the traditional career path?
In this rather quite special episode, we answer all these questions and more with our guests, all of whom are MDs and Harvard MBA students who are pursuing exciting careers off the beaten path:
Suhas Gondi, a MD/MBA student at Harvard Medical School and Harvard Business School, is passionate about healthcare policy and innovation.
Jordan Anderson, a resident physician at Brigham and Women’s Hospital, has interned at start-up Belong Health and is passionate about innovative models of care delivery, and is an MBA student at Harvard Business School.
Lina Vadlamani, MD\MBA Candidate at Yale School of Medicine and HBS, and Sr. Manager, Strategic and Clinical Initiatives at Patina (company innovating in senior care). She's passionate about value-based care, digital health and primary care innovation for vulnerable populations.
How can MDs interested in investing and entrepreneurship break into a very network-driven industry? How can being a doctor in that world helps you differentiate your investing mindset? In this episode, we answer all these questions and more with our guest, Kyle Dempsey, M.D.
Kyle is a partner at MVM Partners LLP, a company that invests in high growth healthcare businesses and has been doing that since 1997.
Kyle has an MD from Harvard Medical School and an MBA from Harvard Business School. He also holds an AB in biochemistry from Bowdoin College.
How can MDs take a more prominent role in driving invention and innovation in healthcare? What will healthcare look like in the age of the metaverse? In this episode, we answer all these questions and more with our guest, Steve Miller, MD.
Steven is the Exec VP/Chief Clinical Officer at Cigna Corp. He has years of expertise as a medical researcher, clinician and administrator, as well as on numerous healthcare subjects.
Steven has an MBA from the Olin School of Business at Washington University in St. Louis and an MD from the University of Missouri–Kansas City. He trained in the Pathology and Research fellowship at the University of Alabama at Birmingham and in cardiology at the University of California, San Francisco.
What is the mission of big corporations in the healthcare business? How can physicians broaden their conception of what impact really means? In this episode, we answer all these questions and more with our guest, Kevin Tabb, MD.
Kevin is President and Chief Executive Officer of Beth Israel Lahey Health (BILH), where he leads a comprehensive integration plan to deliver better access to care for patients.
Kevin received his undergraduate degree from Hebrew University in Jerusalem and his MD from the Hebrew University Hadassah Medical School. He completed his residency in internal medicine at Hadassah Hospital.
What are some of the challenges women still face today in getting access to good healthcare and education opportunities throughout the world? How can physicians broaden their conception of what impact really means? In this episode, we answer all these questions and more with our guest, Claire Wagner, MD.
Claire is head of corporate strategy at Bill & Melinda Gates Medical Research Institute, a global health biotech dedicated to developing pharmaceutical products for some of the world's most complex diseases.
Claire has an MD from Harvard Medical School and an MBA from Harvard Business School, where she was the Commencement Class Day Speaker.
What are the limitations and challenges of pursuing a career outside the traditional career path? How can physicians broaden their conception of what impact really means? In this episode, we answer all these questions and more with our guest, Bobak Azamian, MD.
Bobak is President and CEO of Tarsus Pharmaceuticals, a public biotech company, which revolutionizes therapeutics for essential diseases in eye care, dermatology, and infectious diseases.
Bobak completed an MD from Harvard Medical School (Harvard-MIT Health Sciences and Technology), a PhD in Chemistry from Oxford University as a Rhodes Scholar, and a BA in Physics from Rice University.
How can MDs interested in venture capital and entrepreneurship break into a very network-driven industry? How can being a doctor in the VC world helps you differentiate your investing mindset? In this episode, we answer all these questions and more with our guest, Ben Robbins, M.D.
Ben is a venture partner at GV (formerly Google Ventures), the venture capital investment arm of Alphabet Inc. Ben's investments focus on healthcare delivery and neuropsychiatric therapeutics. He has served on the boards of numerous companies such as Aspire Health and Brightline.
Ben completed psychiatric training at Massachusetts General Hospital. Before that, he received his M.D. from Harvard Medical School, MBA from Harvard Business School, and B.A. with honours from Dartmouth College.
What is the mission of big corporations in the healthcare business? How is AI going to impact the drug development continuum in the next 5-10 years? How essential is the MBA for doctors who want non-traditional careers? In this episode, we answer all these questions and more with our guest, Sachin H. Jain, M.D.
Sachin is the president and CEO of SCAN Group and Health Plan, an HMO, which provides healthcare coverage to Medicare beneficiaries throughout California, currently serving nearly 200,000 members. SCAN is one of the largest NPO Medicare Advantage Prescription Drug plans in the country.
Before this, Sachin was Chief Medical Information & Innovation Officer at Merck & Co. He graduated magna cum laude from Harvard College with a BA in government and continued to earn his MD from Harvard Medical School and MBA from Harvard Business School. He trained in medicine at Brigham and Women's Hospital.
How do investment banking and financial advisory play a role in facilitating the
transformation and innovation in the healthcare ecosystem? Can you develop a business acumen without an MBA degree? In this episode, we answer all these questions and more with our guest, Alex Lomax, M.D.
Alex is a Vice President of Healthcare Financial Advisory at Lazard, the world’s largest financial advisory-focused firm. Lazard advises clients on M&A and Strategic Advisory, Middle Market, Sovereign Advisory, Restructuring, Shareholder & Private Capital Advisory, and Venture & Growth Banking.
Lazard has advised on many of the largest deals in the healthcare space such as the merger of Livongo & Teladoc and the Acquisition of Aetna by CVS health. Before Lazard, Alex was an associate and then vice president of Healthcare Investment Banking at RBC Capital Markets. He was also an Investment Banking Analyst at Peel Hunt for two years.
What are some of the biggest problems facing American healthcare? How should we think about the tradeoffs of private vs public-run healthcare? In this episode, we answer all these questions and more with our guest Elisabeth Rosenthal, MD.
Elisabeth is the editor-in-chief of Kaiser Health News, a contributing Opinion Writer at The New York Times who previously spent 22 years at the Times, and the author of 'An American Sickness', A NY Times best-seller, an eye-opening investigation into America's healthcare system.
A former ER physician, Dr Rosenthal is an award-winning reporter, correspondent, and patient advocate. She has had an immense impact on American healthcare policy and public discourse, and Washingtonian Magazine recently named her one of the most influential people in D.C. right now.
What is the future of Private Equity in the healthcare space? What skills can you leverage from your medical career when you venture off the traditional career path? How can you develop the appropriate tools to manage a high workload and take care of your mental health? In this episode, we answer all these questions and more with our guest Alex Dibelius, MD.
Alex is Managing Partner of CVC Capital Partners in Germany and has been GmbH director since 2016. Previously, he served in several capacities at Goldman Sachs from 1993-2015 and worked as a consultant for McKinsey & Company (a global management consulting firm), where he was appointed partner in 1992. Before his business career, Dr Dibelius was a surgeon at the university clinic of Freiburg, Germany. Alex is also chairman of the board of Breitling SA, Grenchen, Switzerland (a luxury watch manufacturer), and a member of the board of CVC Capital Partners Luxembourg SARL, Luxembourg (a private equity advisor), Syntegon Technology Gmblt, Waiblingen, Germany (a packaging company), IronSource Mobile Ltd, Tel Aviv, Israel (a mobile app monetization company). Alex is an advisor to chancellor Angela Merkel and a member of the German-American elite network Atlantik-Brüke.
What is it like to navigate the healthcare system both as a healthcare professional and as a patient? What is the state of research for rare diseases right now? Is an MBA important for docs to consider? In this episode, we answer all these questions and more with our guest David Fajgenbaum, MD.
David is an assistant professor of medicine in Translational Medicine & Human Genetics at the University of Pennsylvania. He's also the founding director of the center for Cytokine Storm Treatment & Laboratory (CSTL). He is the co-founder/president of the Castleman Disease Collaborative Network (CDCN). David is the national bestselling author of 'Chasing My Cure: A Doctor's Race to Turn Hope Into Action'. The book describes his harrowing and hopeful journey to spearhead the search for a cure for his disease.
What is the difference between venture capital, private equity, and growth equity? What is the value of resilience and grit? And when exactly do you make that defining leap in your career? In this episode, we answer all these questions and more with our guest Mark Shankar, MD.
Mark focuses primarily on healthcare investing at Summit Partners, which invests in growth equity. Prior to Summit, Mark worked on the Healthcare Investment Banking Team at Goldman Sachs. In addition, he served as a clinical assistant professor of emergency medicine at the Columbia University Vagelos College of Physician & Surgeons and was an Emergency Medicine Resident at New York Presbyterian Hospital where he held the position of chief resident. He holds a BA from the University of California, Berkeley, an MD from the George Washington University School of Medicine, and an MBA from Harvard Business School.
What exactly is the role of a physician-consultant? What is the value of working at the intersection of disciplines? And what exciting technology trends are emerging in healthcare? Our guest Dr. Felix Matthews discusses these ideas and more in the first episode of our Physician-Consultant series.
Felix is a Managing Director and physician leader at Deloitte Consulting and is the National Lead for Deloitte's Academic Health/Research Leaders practice. He advises his clients on strategies to succeed in an increasingly competitive market. His clients include academic health systems, national health plans, and life sciences companies.
How do you think about success? How much do you believe in your dreams? How grounded in reality should you really be? In the second installment of our physician-investor series, we had an amazing and candid conversation with Tinashe Chandauka MD/PhD where he answered our questions about his inspirational journey from a young doctor with big dreams to a successful investment professional with great impact!
Tinashe is a lifescience investment professional with an MD/PhD background (Rhodes Scholar/Oxford University). He works as an Associate at Oxford Sciences Innovation, a Science Business Builder (who raised +£630m) at founding to transform Oxford University's world-leading science into world-changing businesses.
Dr. Martin-Immanuel Bittner is the CEO of Arctoris, the world's first fully automated drug discovery platform that he co-founded in Oxford in 2016. His goal is to change the way we approach drug discovery - moving towards a truly data-driven model, with the right data at the right time empowering us to make the right decisions, accelerating the path towards the clinic. He partners with biotech and pharma companies globally, delivering integrated drug discovery projects from idea to IND, enabled by a team of expert scientists and their unique technology platform.
Have you ever wondered about the investing world? In our inaugural episode, we talk to Dr. Dan Gebremedhin, a venture capital partner at Flair Capital. He discusses his journey through medical school and how he went into business, the challenges he faced, and the lessons he learned along the way.
Dan has led investments into and sits on the Boards of Somatus, Eden Health and Votive Health. He was a practicing Internal Medicine Physician at the Massachusetts General Hospital and an instructor at Harvard Medical School until 2019. He has also been an entrepreneur and senior health policy advisor to several politicians such as Governor Charlie Baker and Congressman Joseph Kennedy III.